# Millions Use Marijuana to Cope with Anxiety and Depression, But a Major New Study Says It … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-for-anxiety-and-depression-study-insights/ > **Published:** 2026-03-19T14:02:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:05:10-04:00 > **Clinical Summary:** Explore the latest study on cannabis for anxiety and depression, revealing limited evidence for its effectiveness and potential risks. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthAnxietyResearchSafety Clinical Summary A comprehensive systematic review challenges the widespread clinical assumption that cannabis effectively treats anxiety and depression, finding insufficient evidence to support its use for these conditions despite millions of patients using it for symptom management. The review’s analysis of existing research indicates that while many patients report subjective improvement, rigorous [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) demonstrate limited efficacy and potential risks including paradoxical anxiety exacerbation, particularly with high-THC products. This evidence gap is clinically significant given the prevalence of self-directed [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for mental health and the lack of FDA approval for these indications, highlighting a concerning disconnect between patient perception and empirical evidence. Clinicians should be aware that recommending [cannabis for anxiety](https://cedclinic.com/medical-cannabis-safety-facts/) or depression currently lacks robust evidence support, and patients using cannabis for these purposes should be counseled about limited efficacy data and potential harms. Physicians encountering patients with cannabis-treated anxiety or depression should discuss evidence-based alternatives such as psychotherapy and pharmacotherapy while monitoring for adverse mental health effects if cannabis use continues. Dr. Caplan’s Take “What we’re seeing clinically is that patients often experience short-term symptom relief with cannabis, but the evidence increasingly suggests this masks underlying anxiety and depression rather than treating them, and over time we observe tolerance, dependence, and worsening mood regulation in many of these individuals.” Clinical Perspective While millions of patients self-report using cannabis for anxiety and depression, emerging evidence suggests the relationship between cannabinoid use and mood disorders is more complex than symptom relief alone. A recent large review challenges the therapeutic efficacy of cannabis for these conditions, though the study’s limitations—including heterogeneity in [cannabinoid formulations](https://cedclinic.com/brazil-cannabis-regulatory-framework-new-medical-rules/), dosing regimens, user populations, and outcome measures—warrant careful interpretation before dismissing patient experiences entirely. Clinicians should recognize that perceived symptom improvement may reflect acute anxiolytic effects, placebo response, or self-selection bias rather than sustained clinical benefit, and that regular use may paradoxically worsen anxiety or depression over time in some individuals. When patients with mood disorders present requesting or already using cannabis, a pragmatic approach involves honest discussion about limited evidence for efficacy, potential for dependence, and availability of evidence-based treatments like psychotherapy and pharmacotherapy. Screening for cannabis use in patients with 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Millions+use+marijuana+to+cope+with+anxiety+and+depression%2C+but+a+major+new+study+says+it+...+%40drcaplan&url=https%3A%2F%2Fwww.instagram.com%2Freel%2FDWEnOnkARh5%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.instagram.com%2Freel%2FDWEnOnkARh5%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Millions+use+marijuana+to+cope+with+anxiety+and+depression%2C+but+a+major+new+study+says+it+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.instagram.com%2Freel%2FDWEnOnkARh5%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 239 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-digest-march-17-2026/) - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://www.instagram.com/reel/DWEnOnkARh5/](https://www.instagram.com/reel/DWEnOnkARh5/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Major study finds strong link between cannabis, anxiety and depression – Medical Xpress](https://cedclinic.com/bidirectional-cannabis-anxiety-depression-link/) This article discusses a major study highlighting the connection between cannabis use and mental health conditions like anxiety and depression. [Read More](https://cedclinic.com/bidirectional-cannabis-anxiety-depression-link/) [Study Finds Little Proof Cannabis Helps Most Mental Health Conditions](https://cedclinic.com/cannabis-effectiveness-mental-health-study-limited-evidence/) An in-depth review revealing limited clinical proof that cannabis effectively treats [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/). [Learn More](https://cedclinic.com/cannabis-effectiveness-mental-health-study-limited-evidence/) [Using marijuana to ease anxiety or depression? Science shows the evidence isn't there](https://cedclinic.com/cannabis-for-psychiatric-symptoms-evidence-review/) A scientific perspective on why marijuana may not be effective for treating anxiety or depression despite popular use. [Explore Article](https://cedclinic.com/cannabis-for-psychiatric-symptoms-evidence-review/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).